NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to ...
THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...
People taking the drugs had a lower risk of organ failure and death However, the drugs were associated with an increased risk of diabetic retinopathy THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback